如何向SCI生物医学期刊投稿电子教案

上传人:yuzo****123 文档编号:137575894 上传时间:2020-07-09 格式:PPT 页数:56 大小:1.30MB
返回 下载 相关 举报
如何向SCI生物医学期刊投稿电子教案_第1页
第1页 / 共56页
如何向SCI生物医学期刊投稿电子教案_第2页
第2页 / 共56页
如何向SCI生物医学期刊投稿电子教案_第3页
第3页 / 共56页
如何向SCI生物医学期刊投稿电子教案_第4页
第4页 / 共56页
如何向SCI生物医学期刊投稿电子教案_第5页
第5页 / 共56页
点击查看更多>>
资源描述

《如何向SCI生物医学期刊投稿电子教案》由会员分享,可在线阅读,更多相关《如何向SCI生物医学期刊投稿电子教案(56页珍藏版)》请在金锄头文库上搜索。

1、如何向SCI生物医学期刊投稿,Scientific communication is a two-way process,A scientific experiment is not complete until the result have been published, read, and understood (readable),What Journal Editors Want,What Journal Editors Want,新颖性 重要性 真实性 可读性 重视读者,Getting Oriented,Follow the journals guidelines! Medical

2、 College of Ohio, Toledo Mulford Library http:/mulford.meduohio.edu/instr/ CONSORT Statement for reporting randomized controlled Trials,http:/www.consort-statement.org Uniform Requirements for Manuscripts Submitted to Biomedical Journals,http:/www.icmje.org/,Publishing UAP: unstable angina pectoris;

3、 IL-1: interleukin-1;sIL-2R: soluble interleukin-2 receptor; IL-6: interleukin-6; TNF-: tumor necrosis factor-; IFN-: interferon *P 0.05 compared with control group. (*P 0.05 AMI group vs. control group.),7.讨论(discussion),FUNCTIONS To explain the findings To tell why they are important,Should discus

4、s the implications of results , not repeat them Comparison of results with previous work Discussing limitations your conclusion,Discussion,8.参考文献(References),引用重要的、相关的、已发表的原始文献 以近期文献为主,尤应注意近3年的文献,综述尤强调“新” 核查文献,确保每一个细节均准确无误 正文中引用的文献必须出现在文后参考文献表中 以文中出现先后排列文献序号, 文献15不能出现在9前 不用文献自动生成格式标注,Creput C, Durrb

5、ach A, Samuel D et al. Incidence of renal and Liver rejection and patient survival rate following combined liver and kidney transplantation. Am J Transplant 2003; 3: 348-356. R.G. Uzzo and A.C. Novick, Nephron sparing surgery for renal tumors: indications, techniques and outcomes, J Urol 166 (2001),

6、 p. 6. Sondheimer, N., and Lindquist, S. (2000). Rnq1: an epigenetic modifier of protein function in yeast. Mol. Cell 5, 163-172.,References,Making Your Writing Effectively,Use the first person Verb tenses in the paper: - Present tense - Past tense Avoid abbreviations,USE STOCK PHRASES State the pro

7、blem: To determine whether, we To determine the cause of To investigate To evaluate and validate To answer this question, we To test the hypothesis that, we We asked whether,Making Your Writing Effectively,USE STOCK PHRASES Methods: We measured We studied We assessed We compared,Making Your Writing

8、Effectively,USE STOCK PHRASES Results: We found that Answer: We conclude that These experiments demonstrate that These findings show that These results indicate that Thus, Therefore,Making Your Writing Effectively,Making Your Writing Effectively,Spell out any number that begins a sentence For number

9、 of 10 000 or greater, use a half- space to separate every 3 digits,How to Publish a English Paper,To read the guidelines of authors To scan a recent issue of the journals,How to Choose a Journal,How to Choose a Journal,Scope Prestige Publication lag Acceptance rate Audience Open policy Payments,201

10、0 Cited Information,Editorial Policies,Duplicate publication or submission Copyright transfer Conflict of interest statement Clinical trial registration,1. Duplicate Submission,Acceptable Secondary Publication: Certain types of articles, such as guidelines In the same or another language, especially

11、 in other countries, is justifiable and can be beneficial provided that the following conditions are met,2. Copyright,Copyright transfer agreement Copyright permissions Works made for hire,3. Conflict of interest,An author (or the authors institution), reviewer, or editor has financial or personal r

12、elationships that inappropriately influence (bias) his or her actions (such relationships are also known as dual commitments, competing interests, or competing loyalties). Statement: disclosing all financial and personal relationships that might bias authors work,4. Clinical Trial Registration,The I

13、CMJE member journals will require, as a condition of consideration for publication in their journals, registration in a public trials registry. Medical interventions,ClinicalTrial America ISRCTN Englang ANZCTR Australian, New Zealand UMIN Japan DRKS German ChiCTR Chinese TRIAL Dutch NIPH Japanese CR

14、IS Korean IRCT Iranian ReBEC Portuguese RPCEC Spanish,International Clinical Trials Registry Platform (ICTRP),Manuscript Submission,Follow the journals guidelines Manuscript checklist CONSORT checklist & flow diagram (http:/www.consort-statement.org),Article titled What kind of article Describe the

15、research Why it is worth publishing Not been published before,Writing the Cover Letter,Copyright assignment Affirmation of originality Conflict of interest statement Permission to reprint figures or tables,Authorship Form,Responding to Reviewers Comments,Respond to every comment If you agree with the comment If you disagree with the comment,

展开阅读全文
相关资源
相关搜索

当前位置:首页 > 中学教育 > 教学课件 > 高中课件

电脑版 |金锄头文库版权所有
经营许可证:蜀ICP备13022795号 | 川公网安备 51140202000112号